1-7 of 7
Brandy Menges, PhD
Close
Sort by
Journal Articles

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Alpesh J. Amin, MD MBA, Steven Deitelzweig, MD, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, W. Richey Neuman, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 365.
https://doi.org/10.1182/blood-2018-99-112288
Published: 2018
Journal Articles

The Impact of Chronic Myeloid Leukemia Therapy Management on the Oncology Care Model

Elias J. Jabbour, MD, Martin F Mendiola, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA, Dinara Makenbaeva, MD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2265.
https://doi.org/10.1182/blood-2018-99-112484
Published: 2018
Journal Articles

The Frequency of Venous Thromboembolism (VTE) Prophylaxis Among Patients Hospitalized for Cancer in the US

Alpesh J. Amin, MD, Richey Neuman, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4734.
https://doi.org/10.1182/blood.V130.Suppl_1.4734.4734
Published: 2017
Journal Articles

Impact of Earlier Vs. Later Monitoring on Disease Progression and Economic Outcomes Among Patients with Chronic Myeloid Leukemia in the Real-World Setting

Elias J. Jabbour, MD, Lisa Siegartel, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 2175.
https://doi.org/10.1182/blood.V130.Suppl_1.2175.2175
Published: 2017
Journal Articles

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

Alpesh J. Amin, MD, Richey Neuman, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3416.
https://doi.org/10.1182/blood.V130.Suppl_1.3416.3416
Published: 2017
Journal Articles

Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs

Elias J. Jabbour, MD, Lisa Siegartel, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3378.
https://doi.org/10.1182/blood.V130.Suppl_1.3378.3378
Published: 2017
Journal Articles

Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

Elias Jabbour, MD, Jay Lin, PhD MBA, Lisa R Siegartel, MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA
Journal: Blood
Blood (2016) 128 (22): 3573.
https://doi.org/10.1182/blood.V128.22.3573.3573
Published: 2016